Applied Finance Capital Management, LLC
Position in A — Agilent Technologies, Inc.
CIK 1966007
SAN JUAN, PR
Position in A
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$382,948
+$65,628 QoQ
Shares Held
2,883
+3.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#682
of 1,112 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in A Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Applied Finance Capital Management, LLC holds $20,613,794 across 6 Diagnostics & Research names. A ranks #5 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
18,993 | $9,522,330 | |
| 2 | DHR |
Danaher Corp /De/
|
48,664 | $9,269,518 | |
| 3 | IQV |
Iqvia Holdings Inc.
|
2,915 | $563,236 | |
| 4 | MTD |
Mettler Toledo International Inc/
|
388 | $495,673 | |
| 5 | A |
Agilent Technologies, Inc.
This page
|
2,883 | $382,948 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
722 | $380,089 |
All Filings in A
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $382,948 | 2,883 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $317,320 | 2,784 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $396,644 | 2,915 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $741,606 | 5,778 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $860,646 | 7,293 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $783,532 | 6,698 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $725,436 | 5,400 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $861,184 | 5,800 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $668,372 | 5,156 | Shares | Sole | 2024-07-31 | |
| No filing history on record for this holder in this stock. | ||||||